Amarin Q3 revenue falls 20% on US pricing pressure

What happened

Amarin's third-quarter revenue fell 20% from a year earlier, mostly on lower U.S. sales. U.S. sales dropped 30% on lower net pricing and continued generic competition. The company posted its first quarterly profit in over two years after operating expenses fell 44%.

Confirmed

Global impact / market context

A profit returning after deep cost cuts shows expense control can offset falling sales, but it does not fix weak pricing. If U.S. prices keep sliding, future profit depends on European demand growth and partner Recordati's investment holding up.

Analyst inference

Analysts rate the stock a sell, with two sell ratings and no buy or hold ratings, and a median target of $12.00, only about 0.4% above the October 27 close. That signals little expected upside while U.S. pricing pressure continues.

Analyst inference

What to watch

1. Amarin expects U.S. volumes to stay broadly stable for the rest of 2026, so watch whether volume steadiness is enough to offset continued lower net pricing. Confirmed
2. Watch whether partner-led revenue growth arrives as expected, since Amarin says it depends on market access, pricing, and ordering patterns, which are outside the company's direct control. Proposed
3. Track European in-market demand for VAZKEPA, up 68%, and partner Recordati's investment, because growing partner revenue is the main offset to shrinking U.S. sales. Analyst inference

Evidence

• Original source link unavailable